[Urapidil and dopamine in severe heart failure. A clinical case].
The Authors report their experience with a new vasodilator drug (Urapidil) employed in the management of serious cardiac failure, in a patient who previously didn't respond in a satisfactory manner to a therapy with Dopamine alone. After several days of continuous treatment, the patient was discharged, without any sign of toxic or metabolic reactions.
Balla
E
E
Rianimazione, Ospedale Civile di Mondovì, Cuneo.
Fenoglio
L
L
Ravera
E
E
Bono
D
D
D000368:Aged; D004298:Dopamine / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010879:Piperazines; D014665:Vasodilator Agents; C015568:urapidil; D004298:Dopamine
Urapidil e dopamina nello scompenso cardiaco grave. Caso clinico.